[ad_1]
“I would like to share some information from yesterday’s European Council (EVS) meeting, which discussed the supply, distribution and vaccination process in all EU countries as soon as possible. The President of the European Commission (EC), Ursula von der Leyen, assured us that in the first and second quarters of this year, Lithuania will be able to vaccinate at least 70 percent of the country’s adult population by early summer. This is much more than we are currently vaccinating and that we imagined until recently, ”President G. Nausėda said Friday.
The president said that the amount of vaccine supplied to Lithuania would reach around 4 million doses.
According to him, 70 percent. Vaccination of the population can be achieved “before the coronation of King Mindaugas.”
G. Nausėda stated that to achieve such a level of vaccination, it will be necessary to ensure that an average of 10,000 people are vaccinated per day in February. people, and in the second quarter of this year, up to 34-35 thousand. people a day.
“In other words, if the vaccination rate slows down during the weekend for one reason or another, we have to compensate for the rest of the days of the week, otherwise the math is relentless,” said the head of state.
Following the announcement of this news, G. Nausėda wrote that we cannot waste time now.
“It just came to our knowledge then. We need to open at least 70 vaccination centers in February, create a clear and transparent registration system, ensure that everyone who wants to prevent the disease is vaccinated.
There is no question whether the Lithuanian state can do this. We must. After all, we are talking about people’s lives. If we are not bothered by the opportunity given to us to vaccinate a critical number of citizens, we will have to answer against the people of Lithuania, “the president wrote.
Decisions on other vaccines awaited
He said these changes would be possible due to the expected approval of the Aztrazeneca vaccine in the near future.
“This issue will be discussed next Friday, if the decision is positive, we can expect the arrival of this vaccine in Lithuania already in mid-February. Another big company in the queue is Johnson and Johnson, the head of state said.
The suitability of this vaccine will be considered in March, if the decision is positive: the vaccines of this manufacturer can arrive in Lithuania in April.
The latter is also special because a single dose of vaccine may be necessary.
“The Johnson and Johnson vaccine may only need one unit, and the investigation is currently ongoing,” Nausėda said.
The President pointed out that the transport conditions for the vaccines of the aforementioned companies are much simpler, which would also facilitate the delivery process to Lithuania.
“The vaccine from the last two companies is a so-called cold vaccine, its storage and transport conditions are much simpler and greatly facilitate the same process (logistics, aut. P.)”, he assured.
The head of state said that the biggest challenge in the near future will no longer be the lack of a vaccine, but the ability to distribute the vaccine throughout the country, to vaccinate en masse.
About 60,000 have already been vaccinated. people
Dulkis ‘order on priorities for COVID-19 vaccination called for vaccinating physicians, high-risk patients, residents, and care facility staff first, followed by volunteers and’ other staff at healthcare facilities. personal’.
According to the Department of Statistics, the first dose of the COVID-19 vaccine in Lithuania was administered to more than 57,000 people. people, both doses – almost 9 thousand.
The first shipment of COVID-19 vaccines arrived in Lithuania almost a month ago, and on December 27, doctors started vaccinations early in the morning by doctors fighting coronavirus on a daily basis.
However, vaccination rates vary widely between municipalities, with some municipalities happy to vaccinate older people and others have not yet completed vaccinations for personal health workers.
Older people are not vaccinated in all major cities
Portal tv3.lt According to the data, older people are also vaccinated in Šilalė district. It has already vaccinated more than 100 older adults.
However, the situation in other large cities and districts is the same as in Kaunas district.
According to Delfi, older people living in non-care institutions in Klaipeda are not yet vaccinated because there are not enough vaccines.
The situation is similar in the municipalities and districts of Vilnius, Kaunas, Šiauliai, as well as in Panevėžys and Klaipėda. According to the Vilnius City Municipality, if the vaccine supply is not interrupted, it is likely that vaccination of these people could start in mid-February.
SAM recognizes that vaccines are different
When asked by SAM on Tuesday if it had any data on the vaccination of older people in Lithuania, the ministry replied that it had no data on the vaccination of older people.
On Wednesday, SAM issued a report informing that vaccination progress varies between municipalities.
As indicated in the SAM report, each municipality, after evaluating the circumstances, organizes the vaccination process to meet the needs of the particular municipality, and the quantities of vaccine delivered depend on the pre-specified need for vaccine doses.
“In some municipalities, vaccination for a specific priority group begins earlier than in the rest of the country for a variety of reasons: On the day of vaccination, an antibody test shows that COVID-19 has already arrived, it cannot arrive in the scheduled vaccination “. To date, the lists of reserve persons formed by municipalities (according to priority groups) are of different scope, the number of inhabitants of the municipalities and the size of a specific priority group in a given municipality differ ”, the report reads .
SAM ensures that it constantly monitors the progress of municipal vaccination and, when planning next week’s distribution, evaluates the progress and distributes the vaccines in such a way as to ensure the most uniform progress possible throughout Lithuania.
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.
[ad_2]
